Exosome Diagnostics develops and commercializes biofluid-based diagnostics to deliver personalized precision healthcare that improves lives. The Company develops exosome-based diagnostics technology platform that harvests comprehensive and dynamic molecular information contained within exosomes from various fresh or frozen biofluids to deliver personalized healthcare to guide treatment decisions and in real-time along the entire patient care continuum.
|HQ||Waltham, MA, US||Map|
|Employees (est.) (Jul 2021)||91||(+3%)|
Exosome Diagnostics total Funding
Exosome Diagnostics latest funding size
Time since last funding
|4 years ago|
Exosome Diagnostics investors
|Forbion Capital Partners, NGN Capital, CD-Venture, Arcus Ventures, Qiagen, Tiger Management Corporation, Blue Ridge Capital, Tiger Infrastructure Partners, btov Partners|
Exosome Diagnostics has 1.34k Twitter Followers. The number of followers has increased 0.4% month over month and increased 0.9% quarter over quarter
Tweets last 30 days
Avg. likes per Tweet
Tweets with engagement
When was Exosome Diagnostics founded?
Exosome Diagnostics was founded in 2008.
Who are Exosome Diagnostics key executives?
Exosome Diagnostics's key executives are John Boyce, William Kelly and Thomas McLain.
How many employees does Exosome Diagnostics have?
Exosome Diagnostics has 91 employees.
Who are Exosome Diagnostics competitors?
Competitors of Exosome Diagnostics include Evox Therapeutics, Genome Explorations and Flylife.
Where is Exosome Diagnostics headquarters?
Exosome Diagnostics headquarters is located at 266 2nd Ave #200, Waltham.
Where are Exosome Diagnostics offices?
Exosome Diagnostics has offices in Waltham, Athens, Huntsville, Mobile and in 4 other locations.
How many offices does Exosome Diagnostics have?
Exosome Diagnostics has 9 offices.
Receive alerts for 300+ data fields across thousands of companies